Novel bispecific human antibody platform specifically targeting a fully open spike conformation potently neutralizes multiple SARS-CoV-2 variants.

Authors:
Kim JW; Heo K; Kim HJ; Yoo Y; Cho HS and 14 more

Journal:
Antiviral Res

Publication Year: 2023

DOI:
10.1016/j.antiviral.2023.105576

PMCID:
PMC9979629

PMID:
36870394

Journal Information

Full Title: Antiviral Res

Abbreviation: Antiviral Res

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Anti-Infective Agents

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."

Evidence found in paper:

"Funding sources This research was supported by the Bio & Medical 10.13039/100006180Technology Development Program of the 10.13039/501100003725National Research Foundation of Korea (grant number: NRF-2020M3A9I2107093, NRF-2019M3E5D6063903, and NRF-2016R1A5A1010764) and the Korea Health Technology R&D Project through the 10.13039/501100003710Korea Health Industry Development Institute (grant number: HI22C0360)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025